Sector Gamma As Biomarin Pharmaceutical Inc Transaction History

Sector Gamma As

$297 Million
Q1 2025

A detailed history of Sector Gamma As transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sector Gamma As holds 137,348 shares of BMRN stock, worth $7.99 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares

137,348

Previous 217,348 36.81%

Holding current value

$7.99 Million

Previous $14.3 Million 32.04%

% of portfolio

3.26%

Previous 5.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$61.25 - $72.83 $4.9 Million - $5.83 Million	-80,000 Reduced 36.81%	137,348 $9.71 Million
Q4 2024 Feb 11, 2025	BUY	$61.93 - $70.49 $1.67 Million - $1.9 Million	27,000 Added 14.18%	217,348 $14.3 Million
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $8.77 Million - $11.9 Million	127,000 Added 200.48%	190,348 $13.4 Million
Q2 2024 Aug 09, 2024	SELL	$74.43 - $92.22 $1.34 Million - $1.67 Million	-18,068 Reduced 22.19%	63,348 $5.22 Million
Q1 2024 May 08, 2024	SELL	$83.81 - $99.0 $404,886 - $478,269	-4,831 Reduced 5.6%	81,416 $7.11 Million
Q4 2023 Feb 05, 2024	SELL	$76.22 - $98.51 $747,032 - $965,496	-9,801 Reduced 10.2%	86,247 $8.32 Million
Q3 2023 Nov 06, 2023	SELL	$85.07 - $94.48 $5.67 Million - $6.29 Million	-66,620 Reduced 40.95%	96,048 $8.5 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $547,644 - $633,695	6,318 Added 4.04%	162,668 $14.1 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $117,659 - $157,259	1,341 Added 0.87%	156,350 $15.2 Million
Q4 2022 Feb 07, 2023	BUY	$80.93 - $108.63 $3.67 Million - $4.93 Million	45,405 Added 41.43%	155,009 $16 Million
Q3 2022 Nov 09, 2022	BUY	$82.16 - $96.94 $356,985 - $421,204	4,345 Added 4.13%	109,604 $9.29 Million
Q2 2022 Aug 05, 2022	BUY	$71.48 - $86.85 $1.82 Million - $2.21 Million	25,500 Added 31.97%	105,259 $8.72 Million
Q1 2022 May 06, 2022	SELL	$74.28 - $92.69 $2.51 Million - $3.13 Million	-33,789 Reduced 29.76%	79,759 $6.15 Million
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $8.14 Million - $10.4 Million	113,548 New	113,548 $10 Million
Q3 2021 Oct 29, 2021	SELL	$74.77 - $85.47 $5.16 Million - $5.89 Million	-68,964 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$75.51 - $84.79 $1.72 Million - $1.93 Million	-22,750 Reduced 24.81%	68,964 $5.75 Million
Q1 2021 May 10, 2021	BUY	$74.73 - $90.69 $6.85 Million - $8.32 Million	91,714 New	91,714 $6.93 Million
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $7.8 Million - $14.2 Million	-108,482 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$79.55 - $124.22 $2.47 Million - $3.86 Million	-31,100 Reduced 22.28%	108,482 $13.4 Million
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $4.62 Million - $6.26 Million	64,679 Added 86.35%	139,582 $11.8 Million
Q4 2019 Feb 12, 2020	BUY	$64.27 - $86.37 $4.81 Million - $6.47 Million	74,903 New	74,903 $6.33 Million

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

185M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account